Sithembiso Velaphi to Streptococcus agalactiae
This is a "connection" page, showing publications Sithembiso Velaphi has written about Streptococcus agalactiae.
Connection Strength
1,212
-
Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa. PLoS One. 2019; 14(4):e0214077.
Score: 0,559
-
Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics. 2003 Mar; 111(3):541-7.
Score: 0,183
-
Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
Score: 0,110
-
Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines. 2015; 14(12):1651-60.
Score: 0,109
-
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis. 2015 Apr; 21(4):638-45.
Score: 0,106
-
HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women. J Infect Dis. 2015 Aug 01; 212(3):453-62.
Score: 0,105
-
Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics. 2012 Sep; 130(3):e581-90.
Score: 0,022
-
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009 Dec 05; 374(9705):1909-16.
Score: 0,018